An add-on claim is different from eradication alone
The ACG guideline-author presentation reports insufficient evidence that probiotics improve the efficacy or tolerability of H. pylori eradication therapy. This is a conditional conclusion based on low-quality evidence, not proof that every possible strain has no effect. [1]
It also does not justify choosing a retail strain said to kill the infection without a prescribed regimen. Laboratory inhibition and cure of a human infection are different endpoints. [1]
Symptoms alone do not establish cure
The ACG summary describes defined treatment regimens and emphasizes confirmation of eradication after treatment with appropriate testing. The treating clinician determines the regimen and test preparation. [2]
Feeling better after a supplement is not a replacement for that confirmation. Do not infer that an ulcer-related infection has been cleared from a change in digestive comfort alone. [2]
Keep the measured endpoint attached to the claim
Imagine a study reports less treatment-related diarrhea with an add-on product. That finding, by itself, does not demonstrate that the product alone eradicates H. pylori.
| Detail | Interpretation |
|---|---|
| Tolerability | One possible adjunctive outcome |
| Eradication | A different endpoint |
| Test of cure | Confirms treatment success |

Sources for this article
- Microsoft PowerPoint - ACG 2025 International VGR - Week 5- Howden.pptx
Source consulted: 2026-09-17. This is a reference resource, not a claim that we conducted the studies or tested a product. - ACG Guideline on Treatment of Helicobacter pylori: New Recommendations… Will Practice Change? - American College of Gastroenterology
Source consulted: 2026-09-17. This is a reference resource, not a claim that we conducted the studies or tested a product.